Mankind Pharma IPO Subscription
The Mankind Pharma IPO subscription reflects the demand received from different investor categories during the bidding period. The subscription data includes the number of shares offered, shares bid for, and the subscription multiple (X) for categories such as Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), and Retail Individual Investors (RIIs).
As per the latest subscription update, the Mankind Pharma IPO has received bids for 42,95,12,902 shares against 2,80,41,192 shares offered, resulting in an overall subscription of 15.32x. the NII category is subscribed 3.8x, Retail Investors 0.92x, and QIBs 49.16x.
Subscription Highlights
- Overall Subscription: 15.32x
- QIB Subscription: 49.16x
- NII Subscription: 3.8x
- Retail Subscription: 0.92x
- Retail
- 0.92x
- NII
- 3.8x
- QIB
- 49.16x
- Total
- 15.32x
Current GMP
₹121 (+11.20%)
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
Mankind Pharma IPO Subscription Details ( Tue, 25 Apr 23 11:25 AM)
| Category | Shares Offered | Shares Bid For | Subscription (x) |
|---|---|---|---|
| Qualified Institutions | 8,011,769 | 393,834,103 | 49.16x |
| Non-Institutional | 6,008,827 | 22,822,761 | 3.8x |
| Retail Investors | 14,020,596 | 12,856,038 | 0.92x |
| Total | 28,041,192 | 429,512,902 | 15.32x |
Subscription figures are updated periodically and may change until issue closing. Data reflects bids placed across exchanges.
Application Wise Breakup (Approximate)
| Category | Reserved | Applied | Times (x) |
|---|---|---|---|
| Non-Institutional | - | 0 | - |
| Retail Investors | - | 0 | - |
Subscription figures are updated periodically and may change until issue closing. Data reflects bids placed across exchanges.
Shares bids Against Offered
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Where Can I Check the Mankind Pharma IPO Live Subscription Status?
You can check the Mankind Pharma IPO live subscription status on the IPO Master App or the official websites of the NSE,BSE. The live subscription data is updated regularly during the IPO bidding period and displays category-wise subscription figures for Retail Individual Investors (RII), Non-Institutional Investors (NII), Qualified Institutional Buyers (QIB), Employees (if applicable), and the overall IPO subscription.
What is Mankind Pharma IPO retail subscription status?
The Retail Individual Investor (RII) portion of the Mankind Pharma IPO was subscribed 0.92 times as of Tue, Apr 25, 2023 04:55 PM. The public issue closed on Thu, Apr 27, 2023 for bidding.
How to subscribe Mankind Pharma IPO?
Investors can apply for the Mankind Pharma IPO online through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or via UPI using a SEBI-registered stockbroker or trading app. Select the desired lot size, enter your bid within the price band, and submit your application during the IPO subscription period. The application amount remains blocked in your bank account until the IPO allotment process is completed.
How many times Mankind Pharma IPO subscribed?
The Mankind Pharma IPO was subscribed 15.32x times at the close of bidding period on Thu, Apr 27, 2023.
How to check Mankind Pharma IPO allotment?
The Mankind Pharma IPO allotment was finalized on Wed, May 3, 2023. You can check the Mankind Pharma IPO allotment status on the registrar's website or the BSE/NSE websites using your PAN, application number, or DP/Client ID. You can also check the allotment status quickly through the IPO Master App.
When Will the Mankind Pharma IPO Be Listed?
The Mankind Pharma IPO was listed on Tue, May 9, 2023, on the NSE,BSE.
What is the Mankind Pharma IPO Qualified Institutional Buyers (QIB) subscription status?
The Qualified Institutional Buyers (QIB) category of Mankind Pharma IPO was subscribed 49.16 times as of Tue, Apr 25, 2023 04:55 PM.